Antinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with Biologics

BACKGROUND: With the emergence of biotherapies, accurate diagnosis in early arthritis is needed. At this time, there is no biological marker of psoriatic arthritis. OBJECTIVE: To test whether antinuclear antibodies (ANA) can be used as a diagnostic tool in psoriatic arthritis (PsA), we evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Silvy, Florent, Bertin, Daniel, Bardin, Nathalie, Auger, Isabelle, Guzian, Marie-Caroline, Mattei, Jean-Pierre, Guis, Sandrine, Roudier, Jean, Balandraud, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521886/
https://www.ncbi.nlm.nih.gov/pubmed/26230924
http://dx.doi.org/10.1371/journal.pone.0134218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521886/
https://www.ncbi.nlm.nih.gov/pubmed/26230924
http://dx.doi.org/10.1371/journal.pone.0134218

Ejemplares similares